← Back to Search

One-Legged vs Two-Legged Cycle Training for Idiopathic Pulmonary Fibrosis

N/A
Recruiting
Led By Roger S Goldstein
Research Sponsored by West Park Healthcare Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Confirmed idiopathic pulmonary fibrosis
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at discharge from 8 weeks of pulmonary rehabilitation
Awards & highlights

Summary

This trial will compare the effects of one-legged versus two-legged exercise training in patients with idiopathic pulmonary fibrosis.

Who is the study for?
This trial is for stable patients with confirmed idiopathic pulmonary fibrosis who are enrolled in a pulmonary rehab program. It's not suitable for those who've had a recent exacerbation, finished rehab within the last 6 months, or have other health issues that could make rehab unsafe.
What is being tested?
The study tests if exercising one leg at a time can improve endurance more than the usual two-leg cycling for people with IPF. The idea is to reduce breathing demand during exercise by working fewer muscles simultaneously.
What are the potential side effects?
While specific side effects aren't listed, exercise interventions like these may cause muscle soreness, fatigue, and shortness of breath especially in individuals with lung conditions such as IPF.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with idiopathic pulmonary fibrosis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at discharge from 8 weeks of pulmonary rehabilitation
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at discharge from 8 weeks of pulmonary rehabilitation for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cycle exercise endurance time
Secondary study objectives
health-related quality of life

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: intervention -1-leg cycle trainingExperimental Treatment1 Intervention
Primary aerobic training component one-legged, partitioned, cycle training. A progressive approach to combined intensity and duration will be taken. A cycle starting with intermittent high intensity one-legged exercise progressing to continuous duration of the target duration of 15 min for each leg and then restarting the cycle at a higher intensity.
Group II: usual care - 2-leg cycle trainingActive Control1 Intervention
Primary aerobic training component conventional two-legged cycle training. A progressive approach to combined intensity and duration will be taken. A cycle starting with intermittent high intensity exercise progressing to continuous duration of 30 min and then restarting the cycle at a higher intensity.

Find a Location

Who is running the clinical trial?

West Park Healthcare CentreLead Sponsor
34 Previous Clinical Trials
2,266 Total Patients Enrolled
Roger S GoldsteinPrincipal InvestigatorWest Park Healthcare Centre
1 Previous Clinical Trials
6 Total Patients Enrolled

Media Library

1-leg cycle training Clinical Trial Eligibility Overview. Trial Name: NCT03752892 — N/A
Interstitial Lung Disease Research Study Groups: intervention -1-leg cycle training, usual care - 2-leg cycle training
Interstitial Lung Disease Clinical Trial 2023: 1-leg cycle training Highlights & Side Effects. Trial Name: NCT03752892 — N/A
1-leg cycle training 2023 Treatment Timeline for Medical Study. Trial Name: NCT03752892 — N/A
~4 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top